Duration: PO, 4-24 hr
Understanding the heterogeneity of human pericyte subsets in blood-brain barrier homeostasis and neurological diseases
WO2019239340A1 - Reduced glutathione in a highly soluble, amorphous solid form, and process for the preparation thereof - Google Patents Reduced glutathione in a highly soluble, amorphous solid form, and process for the preparation thereof Download PDF Info Publication number WO2019239340A1 WO2019239340A1 PCT/IB2019/054906 IB2019054906W WO2019239340A1 WO 2019239340 A1 WO2019239340 A1 WO 2019239340A1 IB 2019054906 W IB2019054906 W IB 2019054906W WO 2019239340 A1 WO2019239340 A1 WO 2019239340A1 Authority WO WIPO (PCT) Prior art keywords glutathione reduced glutathione sodium salt product aqueous solution Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
[DOI] [PMC free article] [PubMed] [Google Scholar] Marturano JE, Xylas JF, Sridharan GV, Georgakoudi I, Kuo CK (2014) Lysyl oxidase-mediated collagen crosslinks may be assessed as markers of functional properties of tendon tissue formation
Peptides serve as antiaging agents primarily by increasing the levels of collagen, elastin, and hyaluronic acid, thereby enhancing the elasticity and firmness of the skin (22)